Research progress on the regulation of malignant biological behavior of glioma by miRNA-145

doi:10.3969/j.issn.1672-6731.2024.09.012

Chinese Journal of Contemporary Neurology and Neurosurgery ›› 2024, Vol. 24 ›› Issue (9): 765-771. doi: 10.3969/j.issn.1672-6731.2024.09.012

• Review • Previous Articles Next Articles

Research progress on the regulation of malignant biological behavior of glioma by miRNA-145

Jun-cheng WANG¹, Xin-long LI¹, Dong-ming MA², Ya-wen PAN³^,*()

1. The Second Clinical Medical School, Lanzhou University, Lanzhou 730030, Gansu, China
2. Department of Neurosurgery, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan 750001, Ningxia, China
3. Department of Neurosurgery, The Second Hospital, Lanzhou University; Institute of Neurology, Lanzhou University, Lanzhou 730030, Gansu, China

Received:2024-08-29 Online:2024-09-25 Published:2024-10-10
Contact: Ya-wen PAN
Supported by:
Ningxia Hui Autonomous Region Natural Science Foundation(2021AAC03313); The Sixth Batch of Young Scientists and Technological Talents Promotion Project in Ningxia Hui Autonomous Region in 2021; Yinchuan Science and Technology Plan Project in Ningxia Hui Autonomous Region(2023SF08); Scientific Research Foundation of Ningxia Medical University(XM2020087); Pre-experiment Project of the National Natural Science Foundation of China in People's Hospital of Ningxia Hui Autonomous Region(2021GZRYSY017)

miRNA-145调控胶质瘤恶性生物学行为研究进展

王军成¹, 李欣龙¹, 马东明², 潘亚文³^,*()

1. 730030 兰州大学第二临床医学院
2. 750001 银川, 宁夏回族自治区人民医院神经外科
3. 730030 兰州大学第二医院神经外科兰州大学神经病学研究所

通讯作者: 潘亚文
基金资助:
宁夏回族自治区自然科学基金资助项目(2021AAC03313); 2021年第六批宁夏回族自治区青年科技人才托举工程; 宁夏回族自治区银川市科技计划项目(2023SF08); 宁夏医科大学科学研究基金资助项目(XM2020087); 宁夏回族自治区人民医院国家自然科学基金预实验项目(2021GZRYSY017)

Abstract

Abstract:

Glioma is the most malignant brain tumor with high mortality. Due to its complex biological characteristics such as malignant proliferation, invasion, drug resistance, and immunosuppression, the clinical treatment faces great difficulties. Although the survival rate has improved under surgery combined with radiotherapy and chemotherapy, the overall curative effect is still not obvious. As a kind of non coding RNA (ncRNA), microRNA (miRNA) which has been extensively studied in recent years is involved in the regulation of biological processes of normal tissues and various tumors (including glioma) in human. As a cancer suppressor gene, miRNA-145 plays a regulatory role in the progression of glioma through a variety of pathways, especially as a targeted drug transported to the tumor area through nanocarriers to treat tumors, becoming a current research hotspot. This article summarizes the role of miRNA-145 in pathological grading, tumor microenvironment, the regulation of glioma stem cells, drug resistance, and the prognosis of glioma, aiming to provide the reference for the diagnosis and treatment of glioma.

Key words: Glioma, MicroRNAs, Biomarkers, Review

摘要：

胶质瘤因其恶性增殖、侵袭、耐药性、免疫抑制等复杂的生物学特性，使临床治疗面临极大困难。尽管手术联合放化疗使患者生存率有一定提高，但总体疗效仍不显著。微小RNA（miRNA）作为一种非编码RNA，参与调控多种肿瘤（包括胶质瘤）的生物学过程，抑癌基因miRNA-145通过多种途径在胶质瘤发生与进展中发挥调控作用，尤其是作为靶向药物通过纳米载体运送至肿瘤区域治疗肿瘤成为当前研究热点。本文总结miRNA-145在胶质瘤病理分级、肿瘤微环境、胶质瘤干细胞调控、胶质瘤耐药性及胶质瘤预后中的作用，旨在为胶质瘤的诊断与治疗提供参考。

关键词: 神经胶质瘤, 微RNAs, 生物标记, 综述

Jun-cheng WANG, Xin-long LI, Dong-ming MA, Ya-wen PAN. Research progress on the regulation of malignant biological behavior of glioma by miRNA-145[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(9): 765-771.

王军成, 李欣龙, 马东明, 潘亚文. miRNA-145调控胶质瘤恶性生物学行为研究进展[J]. 中国现代神经疾病杂志, 2024, 24(9): 765-771.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2024.09.012

https://journal11.magtechjournal.com/cjcnn/EN/Y2024/V24/I9/765

Figures/Tables 2

References 57

1	Dai J, Gao J, Dong H. Prognostic relevance and validation of ARPC1A in the progression of low-grade glioma. Aging (Albany NY), 2024, 16: 11162- 11184.
2	Lan B, Zhuang Z, Zhang J, He Y, Wang N, Deng Z, Mei L, Li Y, Gao Y. Triggering of endoplasmic reticulum stress via ATF4-SPHK1 signaling promotes glioblastoma invasion and chemoresistance. Cell Death Dis, 2024, 15: 552. doi: 10.1038/s41419-024-06936-8
3	Tompa M, Galik B, Urban P, Kajtar BI, Kraboth Z, Gyenesei A, Miseta A, Kalman B. On the boundary of exploratory genomics and translation in sequential glioblastoma. Int J Mol Sci, 2024, 25: 7564. doi: 10.3390/ijms25147564
4	Yang XJ, Chen H, Li JB, Sun CY, Yin HF. Integrated and layered diagnoses in the 2021 WHO Classification of Tumors of the Central Nervous System (fifth edition). Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2021, 21: 764- 768. doi: 10.3969/j.issn.1672-6731.2021.09.006
	杨学军, 陈宏, 李佳博, 孙翠云, 尹洪芳. 2021年世界卫生组织中枢神经系统肿瘤分类(第五版)整合及分层诊断解读. 中国现代神经疾病杂志, 2021, 21: 764- 768. doi: 10.3969/j.issn.1672-6731.2021.09.006
5	Yang XJ, Yin HF, Li Zhi, Yu SZ. Chinese version of simplified table of 2021 WHO Classification of Tumors of the Central Nervous System (fifth edition) and translational interpretations. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2021, 21: 746- 750. doi: 10.3969/j.issn.1672-6731.2021.09.004
	杨学军, 尹洪芳, 李智, 于士柱. 2021年世界卫生组织中枢神经系统肿瘤分类(第五版)简表中译版及说明. 中国现代神经疾病杂志, 2021, 21: 746- 750. doi: 10.3969/j.issn.1672-6731.2021.09.004
6	Di W, Fan W, Wu F, Shi Z, Wang Z, Yu M, Zhai Y, Chang Y, Pan C, Li G, Kahlert UD, Zhang W. Clinical characterization and immunosuppressive regulation of CD161(KLRB1) in glioma through 916 samples. Cancer Sci, 2022, 113: 756- 769. doi: 10.1111/cas.15236
7	Liu ZY, Lan T, Tang F, He YZ, Liu JS, Yang JZ, Chen X, Wang ZF, Li ZQ. ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma. BMC Cancer, 2023, 23: 420. doi: 10.1186/s12885-023-10883-6
8	Muragaki Y, Ishikawa E, Maruyama T, Nitta M, Saito T, Ikuta S, Komori T, Kawamata T, Yamamoto T, Tsuboi K, Matsumura A, Nakamura H, Kuroda J, Abe T, Momii Y, Saito R, Tominaga T, Tabei Y, Suzuki I, Arakawa Y, Miyamoto S, Matsutani M, Karasawa K, Nakazato Y, Maebayashi K, Hashimoto K, Ohno T. A multicenter, randomized, placebo-controlled phase Ⅱ b trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomas. J Neurosurg, 2023, 139: 344- 354. doi: 10.3171/2022.12.JNS221221
9	Wu M, Wang T, Ji N, Lu T, Yuan R, Wu L, Zhang J, Li M, Cao P, Zhao J, Li G, Li J, Li Y, Tang Y, Gao Z, Wang X, Cheng W, Ge M, Cui G, Li R, Wu A, You Y, Zhang W, Wang Q, Chen J. Multi-omics and pharmacological characterization of patient-derived glioma cell lines. Nat Commun, 2024, 15: 6740. doi: 10.1038/s41467-024-51214-y
10	Wang X, Yang M, Zhu J, Zhou Y, Li G. Role of exosomal non coding RNAs in ovarian cancer (review). Int J Mol Med, 2024, 54: 87. doi: 10.3892/ijmm.2024.5411
11	Gupta G, Afzal M, Moglad E, Ali H, Singh TG, Kumbhar P, Disouza J, Almujri SS, Kazmi I, Alzarea SI, Hemalatha KP, Goh BH, Singh SK, Dua K. Non-coding RNAs as key regulators of Gasdermin-D mediated pyroptosis in cancer therapy. Pathol Res Pract, 2024, 261: 155490. doi: 10.1016/j.prp.2024.155490
12	Kazlauskiene M, Klimaite R, Kondrotiene A, Dauksa A, Dauksiene D, Verkauskiene R, Zilaitiene B. Plasma miRNA-146b-3p, -222-3p, -221-5p, -21a-3p expression levels and TSHR methylation: diagnostic potential and association with clinical and pathological features in papillary thyroid cancer. Int J Mol Sci, 2024, 25: 8412. doi: 10.3390/ijms25158412
13	Mafi A, Khoshnazar SM, Shahpar A, Nabavi N, Hedayati N, Alimohammadi M, Hashemi M, Taheriazam A, Farahani N. Mechanistic insights into circRNA-mediated regulation of PI3K signaling pathway in glioma progression. Pathol Res Pract, 2024, 260: 155442. doi: 10.1016/j.prp.2024.155442
14	Xu L, Zhang Y, Tang J, Wang P, Li L, Yan X, Zheng X, Ren S, Zhang M, Xu M. The prognostic value and regulatory mechanisms of microRNA-145 in various tumors: a systematic review and Meta-analysis of 50 studies. Cancer Epidemiol Biomarkers Prev, 2019, 28: 867- 881. doi: 10.1158/1055-9965.EPI-18-0570
15	Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res, 2011, 39: D152- D157.(Database issue)
16	Yao D, Chen X. MiRNA-145-5p restrains malignant behaviors of breast cancer cells via downregulating H2AFX expression. Iran J Biotechnol, 2023, 21: e3433.
17	Bai HX, Qiu XM, Xu CH, Guo JQ. MiRNA-145-5p inhibits gastric cancer progression via the serpin family E member 1-extracellular signal-regulated kinase-1/2 axis. World J Gastrointest Oncol, 2024, 16: 2123- 2140. doi: 10.4251/wjgo.v16.i5.2123
18	Du Y. MicroRNA-145 induce apoptosis of glioma cells by targeting BNIP3 and Notch signaling[D]. Hefei: Anhui Medical University, 2018.
	杜妍. MicroRNA-145靶向BNIP3通过Notch信号通路促进神经胶质瘤细胞凋亡[D]. 合肥: 安徽医科大学, 2018.
19	Li XL. Investigate the function and possible mechanisms of miR-145 on the invasion of glioma U251 stem cells[D]. Zhenjiang: Jiangsu University, 2017.
	李晓良. miR-145对胶质瘤U251干细胞侵袭性影响的实验研究[D]. 镇江: 江苏大学, 2017.
20	Koo S, Martin G, Toussaint LG. MicroRNA-145 promotes the phenotype of human glioblastoma cells selected for invasion. Anticancer Res, 2015, 35: 3209- 3215.
21	Xu G, Li JY. Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma. Tumour Biol, 2016, 37: 10577- 10586. doi: 10.1007/s13277-016-4968-3
22	Zhuang Y, Peng H, Mastej V, Chen W. MicroRNA regulation of endothelial junction proteins and clinical consequence. Mediators Inflamm, 2016, ID5078627.
23	Lee SJ, Kim SJ, Seo HH, Shin SP, Kim D, Park CS, Kim KT, Kim YH, Jeong JS, Kim IH. Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma. Cancer Lett, 2012, 320: 72- 80. doi: 10.1016/j.canlet.2012.01.029
24	Chen J, Yang J, Fei X, Wang X, Wang K. CircRNA ciRS-7:a novel oncogene in multiple cancers. Int J Biol Sci, 2021, 17: 379- 389. doi: 10.7150/ijbs.54292
25	Wang HB, Liu Q, Liu YP, Dong W, Wan J, Jiao XH, Wu YQ, Li TZ, Miao HH. Role of the circRNA_34414/miR-6960a-5p/SIRT3 axis in postoperative delirium via CA1 Vglut1+neurons in older mice. CNS Neurosci Ther, 2024, 30: e14902. doi: 10.1111/cns.14902
26	Zhang J, Luo Z, Zheng Y, Duan M, Qiu Z, Huang C. CircRNA as an Achilles heel of cancer: characterization, biomarker and therapeutic modalities. J Transl Med, 2024, 22: 752. doi: 10.1186/s12967-024-05562-4
27	Liu Y, Li R, Wang X, Yang W. CircTTBK2 contributes to the progression of glioma through regulating miR-145-5p/CPEB4 axis. Cancer Manag Res, 2020, 12: 8183- 8195. doi: 10.2147/CMAR.S263586
28	Yin D, Liu L, Shi Z, Zhang L, Yang Y. Ropivacaine inhibits cell proliferation, migration and invasion, whereas induces oxidative stress and cell apoptosis by circSCAF11/miR-145-5p axis in glioma. Cancer Manag Res, 2020, 12: 11145- 11155. doi: 10.2147/CMAR.S274975
29	Chen J, Chen T, Zhu Y, Li Y, Zhang Y, Wang Y, Li X, Xie X, Wang J, Huang M, Sun X, Ke Y. circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma. J Exp Clin Cancer Res, 2019, 38: 398. doi: 10.1186/s13046-019-1376-8
30	Hua L, Huang L, Zhang X, Feng H, Shen B. Knockdown of circular RNA CEP128 suppresses proliferation and improves cytotoxic efficacy of temozolomide in glioma cells by regulating miR-145-5p. Neuroreport, 2019, 30: 1231- 1238. doi: 10.1097/WNR.0000000000001326
31	Raveendran S, Giram A, Elmi M, Ray S, Ireson C, Alavijeh M, Savina IN. Combinatorial therapy: targeting CD133+glioma stem-like cells with a polysaccharide-prodrug complex functionalised gold nanocages. Biomedicines, 2024, 12: 934. doi: 10.3390/biomedicines12050934
32	Abdoli Shadbad M, Nejadi Orang F, Baradaran B. CD133 significance in glioblastoma development: in silico and in vitro study. Eur J Med Res, 2024, 29: 154. doi: 10.1186/s40001-024-01754-2
33	Liu B, Cao Y, Li Y, Ma H, Yang M, Zhang Q, Li G, Zhang K, Wu Y, Zhou Y, Yang W, Sun T. Glioma stem cells upregulate CD39 expression to escape immune response through SOX2 modulation. Cancers (Basel), 2022, 14: 783. doi: 10.3390/cancers14030783
34	Shin I, Park YW, Sim Y, Choi SH, Ahn SS, Chang JH, Kim SH, Lee SK, Jain R. Revisiting gliomatosis cerebri in adult-type diffuse gliomas: a comprehensive imaging, genomic and clinical analysis. Acta Neuropathol Commun, 2024, 12: 128. doi: 10.1186/s40478-024-01832-w
35	Agosti E, Antonietti S, Ius T, Fontanella MM, Zeppieri M, Panciani PP. Glioma stem cells as promoter of glioma progression: a systematic review of molecular pathways and targeted therapies. Int J Mol Sci, 2024, 25: 7979. doi: 10.3390/ijms25147979
36	Zhang Q, Cheng Z, Shi L, Mao G. miR-145-5p inhibits the proliferation of glioma stem cells by targeting translationally controlled tumor protein. J Cancer, 2022, 13: 1490- 1500. doi: 10.7150/jca.65543
37	Li ZJ, Sun DC, Kong CX, Geng YD, Xu CY, Ding BQ. Experimental study of TWIST regulating the expression of miR-145 to promote the invasion and migration of glioma stem cells. Xian Dai Zhong Liu Yi Xue, 2022, 30: 1348- 1353. doi: 10.3969/j.issn.1672-4992.2022.08.002
	李振江, 孙德超, 孔晨旭, 耿亚东, 徐晨阳, 丁炳谦. TWIST调控miR-145表达促进胶质瘤干细胞侵袭、迁移的实验研究. 现代肿瘤医学, 2022, 30: 1348- 1353. doi: 10.3969/j.issn.1672-4992.2022.08.002
38	Zepecki JP, Karambizi D, Fajardo JE, Snyder KM, Guetta-Terrier C, Tang OY, Chen JS, Sarkar A, Fiser A, Toms SA, Tapinos N. miRNA-mediated loss of m6A increases nascent translation in glioblastoma. PLoS Genet, 2021, 17: e1009086. doi: 10.1371/journal.pgen.1009086
39	Katsushima K, Natsume A, Ohka F, Shinjo K, Hatanaka A, Ichimura N, Sato S, Takahashi S, Kimura H, Totoki Y, Shibata T, Naito M, Kim HJ, Miyata K, Kataoka K, Kondo Y. Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun, 2016, 7: 13616. doi: 10.1038/ncomms13616
40	Qian C, Wang B, Zou Y, Zhang Y, Hu X, Sun W, Xiao H, Liu H, Shi L. MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin. Cancer Manag Res, 2019, 11: 6829- 6840. doi: 10.2147/CMAR.S210076
41	Xu Z, Zeng X, Xu J, Xu D, Li J, Jin H, Jiang G, Han X, Huang C. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis. Neuro Oncol, 2016, 18: 830- 839. doi: 10.1093/neuonc/nov298
42	Mao M, Wu Y, He Q. Recent advances in targeted drug delivery for the treatment of glioblastoma. Nanoscale, 2024, 16: 8689- 8707. doi: 10.1039/D4NR01056F
43	Jezierzański M, Nafalska N, Stopyra M, Furgoł T, Miciak M, Kabut J, Gisterek-Grocholska I. Temozolomide (TMZ) in the treatment of glioblastoma multiforme: a literature review and clinical outcomes. Curr Oncol, 2024, 31: 3994- 4002. doi: 10.3390/curroncol31070296
44	Shi Y, Wu M, Liu Y, Hu L, Wu H, Xie L, Liu Z, Wu A, Chen L, Xu C. ITGA5 predicts dual-drug resistance to temozolomide and bevacizumab in glioma. Front Oncol, 2021, 11: 769592. doi: 10.3389/fonc.2021.769592
45	Cheng C, Sun G, Shi L. MiR-145-5p regulates the drug resistance of glioma cells to DMC-BH through TCTP. Zhongguo Zhong Liu Wai Ke Za Zhi, 2022, 14: 278- 284. doi: 10.3969/j.issn.1674-4136.2022.03.014
	程超, 孙关, 石磊. miR-145-5p通过TCTP调节胶质瘤细胞对DMC-BH的耐药性. 中国肿瘤外科杂志, 2022, 14: 278- 284. doi: 10.3969/j.issn.1674-4136.2022.03.014
46	Jia HB, Yan XX, Yuan MZ, Wu JL, Yang J. Effect of serum miR-145-5p on chemosensitivity and its correlation with prognosis of the patients with glioma. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi, 2021, 19: 684- 687. doi: 10.12102/j.issn.1672-1349.2021.04.041
	贾海波, 严肖啸, 袁明智, 武俊丽, 杨婕. 血清miR-145-5p对脑胶质瘤病人化疗敏感性的影响及其与预后的相关性. 中西医结合心脑血管病杂志, 2021, 19: 684- 687. doi: 10.12102/j.issn.1672-1349.2021.04.041
47	Zheng ZT, Zhu Y, Li X. Targeting inhibition of RAD18 expression by miR-145-5p regulates the effect of temozolomide on apoptosis of glioma cells. Zhongguo Lao Nian Xue Za Zhi, 2019, 39: 3661- 3665. doi: 10.3969/j.issn.1005-9202.2019.15.021
	郑忠涛, 祝叶, 李霞. miR-145-5p靶向抑制RAD18表达调控替莫唑胺对脑胶质瘤细胞凋亡的影响. 中国老年学杂志, 2019, 39: 3661- 3665. doi: 10.3969/j.issn.1005-9202.2019.15.021
48	Yang YP, Chien Y, Chiou GY, Cherng JY, Wang ML, Lo WL, Chang YL, Huang PI, Chen YW, Shih YH, Chen MT, Chiou SH. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials, 2012, 33: 1462- 1476. doi: 10.1016/j.biomaterials.2011.10.071
49	Li XM, Wei ZX, Zhang T, Diao XF, Wang B, Zhu CW. Effect of miR-145 combined with temozolomide on malignant behavior of U251 glioma cells. Shi Yong Yi Xue Za Zhi, 2016, 32: 371- 375. doi: 10.3969/j.issn.1006-5725.2016.03.009
	李新茂, 魏志玄, 张婷, 刁新锋, 王博, 朱春伟. miR-145联合替莫唑胺对U251胶质瘤细胞恶性行为的影响. 实用医学杂志, 2016, 32: 371- 375. doi: 10.3969/j.issn.1006-5725.2016.03.009
50	Pan S, Zhao X, Shao C, Fu B, Huang Y, Zhang N, Dou X, Zhang Z, Qiu Y, Wang R, Jin M, Kong D. STIM1 promotes angiogenesis by reducing exosomal miR-145 in breast cancer MDA-MB-231 cells. Cell Death Dis, 2021, 12: 38. doi: 10.1038/s41419-020-03304-0
51	Mendivil-Alvarado H, Limon-Miro AT, Carvajal-Millan E, Lizardi-Mendoza J, Mercado-Lara A, Coronado-Alvarado CD, Rascón-Durán ML, Anduro-Corona I, Talamás-Lara D, Rascón-Careaga A, Astiazarán-García H. Extracellular vesicles and their Zeta potential as future markers associated with nutrition and molecular biomarkers in breast cancer. Int J Mol Sci, 2023, 24: 6810. doi: 10.3390/ijms24076810
52	Buruiană A, Florian SI, Florian AI, Timis TL, Mihu CM, Miclăus M, Osan S, Hrapsa I, Cataniciu RC, Farcas M, Susman S. The roles of miRNA in glioblastoma tumor cell communication: diplomatic and aggressive negotiations. Int J Mol Sci, 2020, 21: 1950. doi: 10.3390/ijms21061950
53	Kurogi R, Nakamizo A, Suzuki SO, Mizoguchi M, Yoshimoto K, Amano T, Amemiya T, Takagishi S, Iihara K. Inhibition of glioblastoma cell invasion by HSA-miR-145-5p and HSA-miR-31-5p co-overexpression in human mesenchymal stem cells. J Neurosurg, 2019, 130: 44- 55.
54	Isachesku E, Braicu C, Pirlog R, Kocijancic A, Busuioc C, Pruteanu LL, Pandey DP, Berindan-Neagoe I. The role of non-coding RNAs in epigenetic dysregulation in glioblastoma development. Int J Mol Sci, 2023, 24: 16320. doi: 10.3390/ijms242216320
55	Goenka A, Tiek DM, Song X, Iglesia RP, Lu M, Hu B, Cheng SY. The role of non-coding RNAs in glioma. Biomedicines, 2022, 10: 2031. doi: 10.3390/biomedicines10082031
56	Lei J, Huang Y, Zhao Y, Zhou Z, Mao L, Liu Y. Nanotechnology as a new strategy for the diagnosis and treatment of gliomas. J Cancer, 2024, 15: 4643- 4655. doi: 10.7150/jca.96859
57	Al-Hawary SIS, Alhajlah S, Olegovich BD, Hjazi A, Rajput P, Ali SHJ, Abosoda M, Ihsan A, Oudah SK, Mustafa YF. Effective extracellular vesicles in glioma: focusing on effective ncRNA exosomes and immunotherapy methods for treatment. Cell Biochem Funct, 2024, 42: e3921. doi: 10.1002/cbf.3921

[1]	Xue-jun YANG. Key points and progress on the diagnosis and treatment of pediatric gliomas [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(9): 695-700.
[2]	Peng SUN, Ma-ding ZHOU, Yu-tong LIU, Jian-xin DU, Gao ZENG. Classification of craniopharyngioma [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(9): 701-705.
[3]	Jing-jing GE, Chen-chen KONG, Chuan ZHAO, Jun-ping ZHANG. Research advances on chemotherapy and targeted therapy of pediatric-type low-grade glioma [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(9): 706-711.
[4]	Wei YANG, Ming GE. Advances on cerebellar mutism syndrome in children after posterior fossa tumor surgery [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(9): 712-716.
[5]	Chuan-wei WANG, Guo-ran DU, Yan-zhao WANG, Shao-lei ZHU, Bin ZHANG, Jie GONG. Progress on diagnosis and treatment of pituitary adenoma in children [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(9): 717-722.
[6]	Jing ZHANG, Peng WANG, Xiao-guang QIU. Single-center study of chemoradiotherapy and targeted therapy for diffuse intrinsic pontine glioma [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(9): 732-738.
[7]	Zhi-yong TONG. Intracranial aneurysms and cerebral revascularization [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(8): 595-598.
[8]	Zhi-yong TONG. History of cerebral revascularization [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(8): 599-605.
[9]	Ling-ji JIN, Jun-wen HU, Yin LI, Lin WANG. Intracranial-intracranial bypass for the treatment of complex intracranial aneurysms: technical advances and surgical experience [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(8): 606-612.
[10]	Pei-xi LIU, Yuan SHI, Wei ZHU. Application of whole-region cerebral vascular bypass for intracranial aneurysms treatment in the flow diversion era [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(8): 613-618.
[11]	Expert Consensus Writing Group on ApoE ε4 and Alzheimer's Disease, Neurodegenerative Disease Special Committee, China Association for Promotion of Health Science and Technology, Yantai Regional Sub Center of China National Clinical Research Center for Neurological Diseases. Expert consensus on the standardized application of ApoE ε4 measurement in Alzheimer's disease [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(8): 657-667.
[12]	Feng ZHANG, Fan-gang MENG. Research progress of subthalamic nucleus deep brain stimulation in treatment of autonomic nerve dysfunction in Parkinson's disease [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(7): 510-515.
[13]	Gui-zhi WU, Hong TIAN. Clinical research progress of deep brain stimulation for Meige's syndrome [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(7): 516-521.
[14]	Fan-gang MENG, Jian-guo ZHANG. Application of retroauricular bone grinding groove technology in deep brain stimulation [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(7): 522-524.
[15]	Lin CHEN, Hua PAN. Electrophysiological diagnosis of functional tremor [J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(7): 573-578.

Please choose a citation manager

Content to export